Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The voltage-dependent calcium channel α2δ subunit is an auxiliary protein component of high-voltage-activated calcium channels, primarily associated with CaV1 and CaV2 channel types. It plays a crucial role in modulating the trafficking, expression, and biophysical properties of these channels. It is the binding site for gabapentinoid drugs used for neuropathic pain.
Binding to the α2δ subunit of voltage-dependent calcium channels, leading to reduced calcium influx and decreased neurotransmitter release.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-dependent Calcium Channel α2δ Subunit (α2δ).